Miracogen
China - ShanghaiBiotechnology
Focus: Miracogen is a China-based biotechnology company specializing in antibody-drug conjugates (ADCs), a targeted oncology modality combining antibodies with cytotoxic payloads. The company operates from Shanghai with limited publicly available scale data.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Miracogen
AI assessmentNot HiringNo open roles listed right now. Follow Miracogen to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT05155839Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)
Phase 1Help build intelligence for Miracogen
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.